Company Operations by Product (Tables)

3 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, Revenue by Product

The following table presents a summary of total revenues by these products: 

	Three Months Ended March 31,
Revenues by Product:	2018		2017
Bloxiverz	$	7,491	$	13,902
Vazculep	12,961		10,179
Akovaz	10,217		25,638
Noctiva	666		—
Other	1,826		2,038
Total product sales	33,161		51,757
License revenue	132		750
Total revenues	$	33,293	$	52,507